We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The ACLA Board of Directors comprises leaders from the nation's top clinical laboratories, dedicated to shaping policies that enhance access to high-quality laboratory services. Price joins an ...
ACLA has been fighting for years against the "flawed" implementation of the Protecting Access to Medicare Act of 2014, which sets laboratory payment rates according to market data reported by industry ...
Trade group American Clinical Laboratory Association warned CMS that “inadequate payment rate[s]” for monkeypox testing may limit patient access. The group recommended a $76.97 payment rate, which it ...
Like for so many industries, 2020 was an unprecedented year for clinical laboratories as they faced growing demand for COVID-19 testing across the U.S. as the pandemic raged. Despite shortages of test ...
A federal court recently rejected arguments by MultiPlan, Inc. and Cigna Health and Life Insurance Company that they had no obligation to ensure payments at the contractually negotiated, in-network ...
The American Clinical Laboratory Association (ACLA) isn’t giving up on its effort to block a payment rule that will cut lab reimbursement by an estimated $670 million next year. On Friday, the ACLA ...
Important developments related to required price reporting to Medicare for clinical laboratories under the Protecting Access to Medicare Act of 2014 (PAMA) have recently occurred. As a result, the ...
Alan Mertz, president of the American Clinical Laboratory Association (ACLA), ripped into the FDA's proposal to regulate lab-developed tests yesterday in a testimony to Congress during a hearing of ...
In late April, FDA made the controversial ruling to amend its regulations on the oversight of laboratory-developed tests (LDT), making explicit that in vitro diagnostic (IVD) products are considered ...
Kadakia is a medical student at Harvard Medical School. Ross and Ramachandran are physicians and professors at the Yale School of Medicine. They submitted an amicus brief in support of the FDA in ACLA ...
The American Clinical Laboratory Association sent a letter to the FDA Sept. 18 calling the agency’s recent regulations on reporting genetic testing results to patients “inappropriate” and “troubling.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results